Neurology, ophthalmology, orl

(Unterschied zwischen Versionen)

Wechseln zu: Navigation, Suche

Version vom 11. Juni 2020, 11:18 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Cerebral embolism
Smell and taste disorder

32310553 2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)

32343122 2020. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement
32320211 ä. Neurological Insights of COVID-19 Pandemic

32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?

32167747 2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host?Virus Interaction, and Proposed Neurotropic Mechanisms
32233443 2020. Letter to the Editor ...Evidence of the COVID-19 Virus Targeting the CNS...
32367205 ä. SARS-CoV-2 can induce brain and spine demyelinating lesions
32377594 ä. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2
32278470 ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19)
32276732 ä. Hearing loss and COVID-19: A note
32327217 ä. COVID-19 and hearing difficulties
32345857 2020. COVID-19 and Neuroinvasion
32345855 2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm?
32265202 2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease

32240762 ä. Nervous system involvement after infection with COVID-19 and other coronaviruses
32360440 ä. Guillain-Barre syndrome as a complication of SARS-CoV-2 infection

32311495 ä. Nervous system damage after COVID-19 infection: presence or absence?
32335192 ä. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
32305574 ä. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020
32298803 ä. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms?
32283294 ä. Encephalitis as a clinical manifestation of COVID-19

32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32283246 ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now
32284146 ä. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)

32323704 2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis
32266761 2020. Neurological manifestations in COVID19 caused by SARS-CoV?2
32354654 ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy

32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms

32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review

32367431 ä. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

32362868 2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
32333104 ä. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis
32328758 ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
32363146 2020. COVID-19 Presenting with Seizures
32313807 2020. Guillain-Barre Syndrome associated with SARS-CoV-2 infection
32373467 2020. Conjunctivitis can be the only presenting sign and symptom of COVID-19

32251791 2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
32314322 ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights
32332516 2020. Precaution and prevention of coronavirus disease 2019 infection in the eye
32353982 2020. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual Ocular Route Exist?
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32312628 ä. Guillain Barre syndrome associated with COVID-19 infection: A case report
32354690 ä. COVID 19 infection presenting as motor peripheral neuropathy
32327279 ä. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis
32334847 ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context
32165057 2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?

32333166 ä. Guillain-Barre syndrome following COVID-19: new infection, old complication?

32299010 ä. Neurotropism of SARS-CoV 2: Mechanisms and manifestations

32299017 2020. Central nervous system manifestations of COVID-19: A systematic review

32275288 ä. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China

32246917 2020. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?
32361098 2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?

32302082 ä. Guillain-Barre Syndrome Associated with SARS-CoV-2
32294339 ä. Neurologic Features in Severe SARS-CoV-2 Infection
32350026 2020. Guillain-Barre syndrome related to COVID-19 infection
32346843 ä. Neurological Implications of COVID-19 Infections
32364120 ä. PACIENTE CON CLINICA NEUROLOGICA COMO UNICA MANIFESTACION DE INFECCION POR SARS-CoV-2.
32364123 ä. Sindrome de Guillain Barre asociado a infeccion por SARS-CoV-2.

[ Sindrome de Guillain-Barre fatal tras infeccion por el virus SARS-CoV-2. Neurology 2020. PMID 32376041 PMID: 32376041 was deleted because it is a duplicate of PMID: 32364124]

32364121 ä. Infeccion por SARS-CoV-2 asociada a diplopia y anticuerpos antirreceptor de acetilcolina

32322398 2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?
32175797 2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
32289466 2020. The evidence of SARS-CoV-2 infection on ocular surface
32359840 ä. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients
32359841 ä. A Rashomon Moment? Ocular Involvement and COVID-19

32329044 2020. Complicaciones neurologicas por coronavirus y COVID-19
32359804 ä. Covid-19 and Guillain-Barr� syndrome: More than a coincidence!
32334841 ä. COVID-19 may induce Guillain-Barr� syndrome
32246403 ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32366614 2020. Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management
32284735 2020. Potential neurological symptoms of COVID-19
32378854 2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom

32359765 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System

32285431 2020. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know
32223077 ä. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID?19
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32336042 2020. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19

32327427 2020. Myositis as a manifestation of SARS-CoV-2
32086236 2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear

32371417 2020. Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection
32379592 2020. Emerging evidence for neuropsycho-consequences of COVID-19
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?

32333487 2020. Does SARS-Cov-2 invade the brain? Translational lessons from animal models

32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum?

32317428 2020. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?

32104915 ä. The neuroinvasive potential of SARS?CoV2 may play a role in the respiratory failure of COVID?19 patients

32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19

32352575 2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients"
32246783 ä. Response to Commentary on ?The neuroinvasive potential of SARS?CoV?2 may play a role in the respiratory failure of COVID?19 patients?
32374427 2020. Expression of the COVID-19 receptor ACE2 in the human conjunctiva
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32330304 2020. Conjunctivitis and COVID-19: A meta-analysis
32320066 2020. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients
32314810 2020. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)

32293714 2020. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019
32275079 2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva

32312873 2020. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020

32275291 2020. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines
32267483 2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19

32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration

32380269 ä. The COVID-19 pandemic: consideration for brain infection

32358218 2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
32345728 2020. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19
32327489 2020. Neurologic manifestations in an infant with COVID-19
32303650 2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19

32369434 2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?

32228363 2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
32338254 2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss
32319971 2020. Anosmia as a prominent symptom of COVID-19 infection
32240279 2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?
32277751 2020. Presentation of new onset anosmia during the COVID-19 pandemic
32320129 2020. Explanation for COVID-19 infection neurological damage and reactivations
32220634 2020. Sars-Cov-2: Underestimated damage to nervous system
32316719 2020. Expression analysis of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues
32306616 2020. Strengthening basic and clinical research on ocular infection caused by coronavirus

C7200324 ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies?
32402785 ä. Neurologic Involvement in COVID-19: Radiologists? Perspective

32377594 2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2

32389704 ä. Pain: A potential new label of COVID-19
32387508 ä. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis
32387343 ä. SARS-CoV-2: ?Three-steps? infection model and CSF diagnostic implication
32387342 ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19
32389893 2020. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature

32382463 ä. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease
32382146 ä. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea

32313807 2020. Guillain-Barre Syndrome associated with SARS-CoV-2 infection
32378132 ä. COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist?s Perspective
32409210 ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases
32409215 ä. Neurological manifestations and complications of COVID-19: A literature review
32417124 ä. COVID-19, SARS and MERS: A neurological perspective

32464367 2020. The neurology of COVID-19 revisited: ...to implement international neurological registries
32413767 2020. Myasthenic crisis in COVID-19

32387762 2020. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report

32355557 ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities

32364124 ä. Syndrome de Guillain-Barre fatal tras infeccion por el virus SARS-CoV-2
C7198200 ä. Syndrome de Guillain-Barre asociado a infeccion por Covid-19

32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection

32380269 2020. The COVID-19 Pandemic: Consideration for Brain Infection

32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome

@@ Zeile 4: / Zeile 4: @@
 {{tp|p=32310553|t=2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}}
-{{tp|p=32119409|t=2020. Neuroanatomy, Nucleus Gustatory|pdf=https://www.ncbi.nlm.nih.gov/books/NBK554522/#article-36422.s6|usr=}}
-{{tp|p=32295727|t=ä. Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report |pdf=|usr=}}
 {{tp|p=32343122|t=2020. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System  Involvement |pdf=|usr=}}
 {{tp|p=32320211|t=ä. Neurological Insights of COVID-19 Pandemic |pdf=|usr=}}
-{{tp|p=C7160911|t=ä. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples  Allowing Earlier Virus Detection |pdf=|usr=}}
 {{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}}
 {{tp|p=32167747|t=2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host?Virus Interaction, and Proposed Neurotropic Mechanisms |pdf=|usr=}}
@@ Zeile 20: / Zeile 20: @@
 {{tp|p=32345855|t=2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors:  Pain After the Storm?|pdf=|usr=}}
 {{tp|p=32265202|t=2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease |pdf=|usr=}}
-{{tp|p=32362452|t=ä. The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19) |pdf=|usr=}}
 {{tp|p=32240762|t=ä. Nervous system involvement after infection with COVID-19 and other coronaviruses |pdf=|usr=}}
 {{tp|p=32360440|t=ä. Guillain-Barre syndrome as a complication of SARS-CoV-2 infection |pdf=|usr=}}
-{{tp|p=32353521|t=ä. Potentially irreversible olfactory and gustatory impairments in COVID-19: indolent vs  fulminant SARS-CoV-2 neuroinfection |pdf=|usr=}}
 {{tp|p=32311495|t=ä. Nervous system damage after COVID-19 infection: presence or absence?|pdf=|usr=}}
 {{tp|p=32335192|t=ä. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?|pdf=|usr=}}
@@ Zeile 34: / Zeile 34: @@
 {{tp|p=32284146|t=ä. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
-{{tp|p=32357210|t=ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19) |pdf=|usr=}}
-{{tp|p=32215618|t=ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study |pdf=|usr=}}
 {{tp|p=32323704|t=2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis |pdf=|usr=}}
 {{tp|p=32266761|t=2020. Neurological manifestations in COVID19 caused by SARS-CoV?2 |pdf=|usr=}}
@@ Zeile 42: / Zeile 41: @@
 {{tp|p=32283980|t=2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms |pdf=|usr=}}
-{{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}}
 {{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}}
-{{tp|p=32253535|t=ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study |pdf=|usr=}}
-{{tp|p=32328771|t=ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19 |pdf=|usr=}}
-{{tp|p=32303881|t=ä. Possible link between anosmia and COVID-19: sniffing out the truth |pdf=|usr=}}
-{{tp|p=32309267|t=2020. Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?|pdf=|usr=}}
-{{tp|p=32329813|t=2020. Defining the burden of olfactory dysfunction in COVID-19 patients |pdf=|usr=}}
 {{tp|p=32367431|t=ä. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain |pdf=|usr=}}
@@ Zeile 58: / Zeile 52: @@
 {{tp|p=32313807|t=2020. Guillain-Barre Syndrome associated with SARS-CoV-2 infection |pdf=|usr=}}
 {{tp|p=32373467|t=2020. Conjunctivitis can be the only presenting sign and symptom of COVID-19 |pdf=|usr=}}
-{{tp|p=32307026|t=ä. Olfactory and taste disorder: The first and only sign in a patient with SARS-CoV-2 pneumonia |pdf=|usr=}}
 {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
@@ Zeile 75: / Zeile 69: @@
 {{tp|p=32299010|t=ä. Neurotropism of SARS-CoV 2: Mechanisms and manifestations |pdf=|usr=}}
 {{ttp|p=32299017|t=2020. Central nervous system manifestations of COVID-19: A systematic review |pdf=|usr=}}
-{{tp|p=32366299|t=2020. Early recovery following new onset anosmia during the COVID-19 pandemic ? an observational cohort study |pdf=|usr=}}
-{{tp|p=32320008|t=ä. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection |pdf=|usr=}}
 {{tp|p=32275288|t=ä. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019  in Wuhan, China |pdf=|usr=}}
 {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}}
-{{tp|p=32304632|t=ä. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 |pdf=|usr=}}
-{{tp|p=32304629|t=ä. Smell and taste dysfunction in patients with COVID-19 |pdf=|usr=}}
 {{tp|p=32246917|t=2020. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?|pdf=|usr=}}
 {{tp|p=32361098|t=2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?|pdf=|usr=}}
-{{tp|p=32344276|t=ä. COVID-19 and Anosmia in Tehran, Iran |pdf=|usr=}}
-{{tp|p=32305563|t=ä. Features of anosmia in COVID-19 |pdf=|usr=}}
 {{tp|p=32302082|t=ä. Guillain-Barre Syndrome Associated with SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32294339|t=ä. Neurologic Features in Severe SARS-CoV-2 Infection |pdf=|usr=}}
@@ Zeile 110: / Zeile 99: @@
 {{tp|p=32284735|t=2020. Potential neurological symptoms of COVID-19 |pdf=|usr=}}
 {{tp|p=32378854|t=2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom |pdf=|usr=}}
-{{tp|p=32298782|t=ä. Anosmia in a healthcare worker with COVID-19 in Madrid, Spain |pdf=|usr=}}
 {{tp|p=32359765|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System |pdf=|usr=}}
-{{tp|p=32313712|t=ä. Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection |pdf=|usr=}}
 {{tp|p=32285431|t=2020. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know |pdf=|usr=}}
@@ Zeile 126: / Zeile 115: @@
 {{tp|p=32333819|t=2020. COVID-19: what if the brain had a role in causing the deaths?|pdf=|usr=}}
 {{ttp|p=32333487|t=2020. Does SARS-Cov-2 invade the brain? Translational lessons from animal models |pdf=|usr=}}
-{{tp|p=32320508|t=2020. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study |pdf=|usr=}}
 {{ttp|p=32301553|t=2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum?|pdf=|usr=}}
-{{tp|p=32342566|t=2020. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases |pdf=|usr=}}
 {{tp|p=32317428|t=2020. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?|pdf=|usr=}}
-{{tp|p=32366336|t=2020. Olfactory and gustatory dysfunction caused by SARS-CoV-2: comparison with cases of infection with influenza and other viruses |pdf=|usr=}}
-{{tp|p=32342636|t=2020. Potential pathogenesis of ageusia and anosmia in COVID-19 patients |pdf=|usr=}}
-{{tp|p=32329222|t=2020. Self-reported olfactory loss associates with outpatient clinical course in Covid-19 |pdf=|usr=}}
-{{tp|p=32301284|t=2020. Smell dysfunction: a biomarker for COVID-19 |pdf=|usr=}}
 {{ttp|p=32104915|t=ä. The neuroinvasive potential of SARS?CoV2 may play a role in the respiratory failure of COVID?19 patients |pdf=|usr=}}
@@ Zeile 145: / Zeile 131: @@
 {{tp|p=32320066|t=2020. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients |pdf=|usr=}}
 {{tp|p=32314810|t=2020. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) |pdf=|usr=}}
-{{tp|p=32311107|t=2020. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients |pdf=|usr=}}
 {{tp|p=32293714|t=2020. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019 |pdf=|usr=}}
 {{tp|p=32275079|t=2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva |pdf=|usr=}}
@@ Zeile 151: / Zeile 137: @@
 {{tp|p=32312873|t=2020. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 |pdf=|usr=}}
-{{tp|p=32237238|t=ä. Anosmia and Ageusia: Common Findings in COVID?19 Patients |pdf=|usr=}}
 {{tp|p=32275291|t=2020. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines |pdf=|usr=}}
 {{tp|p=32267483|t=2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 |pdf=|usr=}}
@@ Zeile 158: / Zeile 144: @@
 {{tp|p=32380269|t=ä. The COVID-19 pandemic: consideration for brain infection |pdf=|usr=}}
-{{tp|p=32379311|t=ä. Letter: Anosmia in COVID-19: Severe Acute Respiratory Syndrome Coronavirus 2 Through the Nasoliary Epithelium and a Possible Spreading Way to the Central Nervous System?A Purpose to Study |pdf=|usr=}}
 {{tp|p=32358218|t=2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy |pdf=|usr=}}
 {{tp|p=32345728|t=2020. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 |pdf=|usr=}}
 {{tp|p=32327489|t=2020. Neurologic manifestations in an infant with COVID-19 |pdf=|usr=}}
 {{tp|p=32303650|t=2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 |pdf=|usr=}}
-{{tp|p=32333489|t=2020. Is gustatory impairment the first report of an oral manifestation in COVID-19?|pdf=|usr=}}
 {{tp|p=32369434|t=2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?|pdf=|usr=}}
-{{tp|p=32369429|t=2020. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis |pdf=|usr=}}
-{{tp|p=32366195|t=2020. Anosmia and the Need for COVID-19 Screening during the Pandemic |pdf=|usr=}}
-{{tp|p=32366161|t=2020. Olfactory Dysfunction in COVID-19 |pdf=|usr=}}
-{{tp|p=32366160|t=2020. Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health  Significance |pdf=|usr=}}
-{{tp|p=32340555|t=2020. COVID-19 Anosmia Reporting Tool: Initial Findings |pdf=|usr=}}
-{{tp|p=32366595|t=2020. Acute anosmia from COVID-19 infection |pdf=|usr=}}
 {{tp|p=32228363|t=2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features |pdf=|usr=}}
 {{tp|p=32338254|t=2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss |pdf=|usr=}}
@@ Zeile 183: / Zeile 164: @@
 {{tp|p=C7200324|t=ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies? |pdf=|usr=}}
 {{tp|p=32402785|t=ä. Neurologic Involvement in COVID-19: Radiologists? Perspective |pdf=|usr=}}
-{{tp|p=C7160911|t=ä. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples  Allowing Earlier Virus Detection |pdf=|usr=}}
-{{tp|p=32386948|t=ä. 18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19 |pdf=|usr=}}
 {{tp|p=32377594|t=2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 |pdf=|usr=}}
@@ Zeile 196: / Zeile 176: @@
 {{tp|p=32382463|t=ä. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease |pdf=|usr=}}
 {{tp|p=32382146|t=ä. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival  and pterygium cell lines and in mouse cornea |pdf=|usr=}}
-{{tp|p=32387496|t=ä. Taste Changes (Dysgeusia) in COVID-19: A systematic review and metaanalysis |pdf=|usr=}}
 {{tp|p=32313807|t=2020. Guillain-Barre Syndrome associated with SARS-CoV-2 infection |pdf=|usr=}}
 {{tp|p=32378132|t=ä. COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist?s Perspective |pdf=|usr=}}
@@ Zeile 210: / Zeile 190: @@
 {{tp|p=32355557|t=ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities |pdf=|usr=}}
-{{tp|p=32289035|t=2020. Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation |pdf=|usr=}}
 {{tp|p=32364124|t=ä. Syndrome de Guillain-Barre fatal tras infeccion por el virus SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=C7198200|t=ä. Syndrome de Guillain-Barre asociado a infeccion por Covid-19 |pdf=|usr=}}

Neurology, ophthalmology, orl

Version vom 11. Juni 2020, 11:18 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge